Back to Capital Research Global Investors Capital Research Global Investors

HAHAE
Showing 5 of 28 quarters

Position history for Capital Research Global InvestorsCapital Research Global Investors's holdings in HAEMONETICS CORP MASS

Capital Research Global Investors previously held 0 shares of HAE (HAEMONETICS CORP MASS), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$357.1M

Total Shares Change

-4.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$48.12
0
2025-Q2
Decreased
1.1M
-27.8%
$85M0.0%$73.80
0
2025-Q1
Decreased
1.6M
-62.8%
$100.2M0.0%$63.19
0
2024-Q4
Decreased
4.2M
-4.6%
$331M0.1%$76.60
0
2024-Q3
Decreased
4.4M
-35.8%
$357.1M0.1%$79.80
0

Other major holders of HAE: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used